뮤라야폴린 에이를 함유하는 심장 질환의 예방 및 치료용 조성물
    1.
    发明授权
    뮤라야폴린 에이를 함유하는 심장 질환의 예방 및 치료용 조성물 有权
    包含MURRAYAFOLINE A用于治疗和预防心脏疾病的组合物

    公开(公告)号:KR101045027B1

    公开(公告)日:2011-06-30

    申请号:KR1020100107621

    申请日:2010-11-01

    CPC classification number: A61K31/404 A23L29/035 A23L29/045 A23V2200/326

    Abstract: PURPOSE: A composition containing Glycosmis stenocarpa(Drake) Tan-derived murrayafoline A is provided to enhance contraction of heart chamber muscle and to prevent and treat heart diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating heart diseases contains murrayafoline A of chemical formula 1 as an active ingredient. A health food for preventing or treating heart diseases contains murrayafoline A of chemical formula 1. The health food is manufactured in the form of dairy products such as drinks, meat, sausage, and noodles; beverages; and supplementary nutritious products including alcoholic drinks and vitamin complex.

    Abstract translation: 目的:提供含有Glycosmis stenocarpa(德雷克)Tan衍生的Murrayafoline A的组合物,以增强心室肌肉的收缩并预防和治疗心脏病。 构成:用于预防或治疗心脏病的药物组合物含有作为活性成分的化学式1的假单胞菌素A. 一种用于预防或治疗心脏病的保健食品含有化学式1的murrayafoline A.保健食品以饮料,肉类,香肠和面条等乳制品的形式制造。 饮料; 补充营养产品,包括酒精饮料和维生素复合物。

Patent Agency Ranking